Table of Contents

November 01, 2002; Volume 27,Issue 6

Editorial

You have access
Chirality and drugs used to treat psychiatric disorders
Glen B. Baker, Trevor I. Prior and Ronald T. Coutts

J Psychiatry Neurosci November 01, 2002 27 (6) 401-403;

Commentary

You have access
Drug-metabolizing cytochrome P450s in the brain
Sharon L. Miksys and Rachel F. Tyndale

J Psychiatry Neurosci November 01, 2002 27 (6) 406-415;

Research Papers

You have access
Reboxetine: a preliminary report on its use through the Special Access Program
Sidney H. Kennedy, Raymond W. Lam, Nicole L. Cohen, Michael Rosenbluth, Stephen T.H. Sokolov, Roger S. McIntyre, Pierre Chue and Gerry Craigen; for the Canadian Network for Mood and Anxiety Treatments (CANMAT)

J Psychiatry Neurosci November 01, 2002 27 (6) 418-422;
You have access
Suicide in Israel: 1985–1997
Ricardo Nachman, Ornit Yanai, Leib Goldin, Marnina Swartz, Yoram Barak and Jehuda Hiss

J Psychiatry Neurosci November 01, 2002 27 (6) 423-428;
You have access
Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects
Nicholas J. Delva, Deborah L. Brooks, Michael Franklin, Khalid Al-Said, Emily R. Hawken, Zul Merali, J. Stuart Lawson and Arun V. Ravindran

J Psychiatry Neurosci November 01, 2002 27 (6) 429-437;

CCNP News and Views

You have access
The 25th Annual Meeting of the Canadian College of Neuropsychopharmacology
Marco Leyton, Simon N. Young and Lalit K. Srivastava

J Psychiatry Neurosci November 01, 2002 27 (6) 438-450;

Book Reviews

You have access
Handbook of Functional Neuroimaging of Cognition
Cheryl L. Grady

J Psychiatry Neurosci November 01, 2002 27 (6) 451;
You have access
Neurobiology of Mental Illness
Pavel Hrdina

J Psychiatry Neurosci November 01, 2002 27 (6) 451-452;

Psychopharmacology for the Clinician

You have access
Should some drugs be avoided when treating bulimia nervosa?
Mimi Israël

J Psychiatry Neurosci November 01, 2002 27 (6) 457;